人工智能辅助结肠镜检测结直肠病变的有效性:随机对照试验的系统评价与荟萃分析。
完整摘要 · 中文译文
背景:结肠镜检查是结直肠癌检测和预防的金标准,但其性能取决于操作者技能和病变特征。人工智能(AI)辅助结肠镜检查已被引入以提高腺瘤检出率。 方法:在PubMed、Embase、Cochrane图书馆、Web of Science、ClinicalTrials.gov及主要中文数据库中进行了全面检索,以识别比较AI辅助结肠镜检查与传统结肠镜检查的随机对照试验(RCT)。使用Review Manager 5.4和Stata 14.0进行荟萃分析。证据质量采用推荐分级的评估、制定与评价(GRADE)系统进行分级,同时应用试验序贯分析(TSA)评估结果的稳健性和信息充分性。 结果:共纳入46项RCT,涵盖37,012名参与者。与传统结肠镜检查相比,AI辅助结肠镜检查与更高的腺瘤检出率(ADR:RR = 1.22,95% CI = 1.17-1.27,P < 0.00001)、息肉检出率(PDR:RR = 1.22,95% CI = 1.16-1.29,P < 0.00001)、每次结肠镜检查的息肉检出数(PPC:MD = 0.28,95% CI = 0.21-0.36)及每次结肠镜检查的腺瘤检出数(APC:MD = 0.22,95% CI = 0.15-0.29)相关。AI辅助组无蒂锯齿状病变(SSL)的检出率也更高(RR = 1.20,95% CI:1.05-1.36,P = 0.007),而进展期腺瘤检出率(AADR)未观察到显著差异。 结论:AI辅助结肠镜检查与多项检测相关质量的改善相关 指标,包括ADR、PDR、PPC、APC和SSL检出率。然而,鉴于ADR和PDR的GRADE证据确定性极低且缺乏长期结局数据,这些发现应谨慎解读。 临床试验编号:不适用。
完整摘要 · 英文原文
BACKGROUND: Colonoscopy is the gold standard for colorectal cancer detection and prevention, but its performance depends on operator skill and lesion features. Artificial intelligence (AI)-assisted colonoscopy has been introduced to improve adenoma detection. METHODS: A comprehensive search was conducted in PubMed, Embase, the Cochrane Library, Web of Science, ClinicalTrials.gov, and major Chinese databases to identify randomized controlled trials (RCTs) comparing AI-assisted and conventional colonoscopy. Meta-analyses were performed using Review Manager 5.4 and Stata 14.0. The quality of evidence was graded using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system, while trial sequential analysis (TSA) was applied to assess the robustness and information sufficiency of the results. RESULTS: A total of 46 RCTs encompassing 37,012 participants were included. Compared with conventional colonoscopy, AI-assisted colonoscopy was associated with a higher ADR (RR = 1.22, 95% CI = 1.17-1.27, P < 0.00001), polyp detection rate (PDR: RR = 1.22, 95% CI = 1.16-1.29, P < 0.00001), polyp detection per colonoscopy (PPC: MD = 0.28, 95% CI = 0.21-0.36), and adenoma detection per colonoscopy (APC: MD = 0.22, 95% CI = 0.15-0.29). The detection rate of sessile serrated lesions (SSL) was also higher in the AI-assisted group (RR = 1.20, 95% CI: 1.05-1.36, P = 0.007), whereas no significant difference was observed in advanced adenoma detection rate (AADR). CONCLUSIONS: AI-assisted colonoscopy was associated with improvements in several detection-related quality indicators, including ADR, PDR, PPC, APC, and SSL detection rate. However, given the very low GRADE certainty for ADR and PDR and the lack of long-term outcome data, these findings should be interpreted cautiously. CLINICAL TRIAL NUMBER: Not applicable.